Richard Bartram

Insider Reports History

Entity
Individual
Location
C/O Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Richard Bartram
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Bartram:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Financial Officer Common Stock 82.8K $103K $1.25 Mar 14, 2022 Direct
Esperion Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy 159K Mar 14, 2022 Direct
MBX Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 42.6K Sep 12, 2024 Direct

Insider Reports Filed by Richard Bartram

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MBX MBX Biosciences, Inc. Sep 12, 2024 1 $0 4 Sep 13, 2024 Chief Financial Officer
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2022 1 $0 4 Mar 16, 2022 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Oct 29, 2021 1 $0 4 Nov 1, 2021 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Jun 28, 2021 2 $0 4 Jun 30, 2021 Chief Financial Officer